MarketResearch.biz delivers in-depth insights on the global biopsy devices market in its upcoming report titled, “Global Biopsy Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026”. The global biopsy devices market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the global biopsy devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report offers insightful and detailed information regarding the various key players operating in the global biopsy devices market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global biopsy devices market report has been segmented on the basis of device type, application, imaging technology, end-user, and region.
Biopsy is a medical test performed to examine and remove cancerous tissue from the body. Biopsy is mainly used to determine the presence or extent of a disease by surgical removal of tissue of an organ – mostly cancerous or inflammatory in nature. Biopsy is mainly performed by skilled surgeons, radiologists, and cardiologists, to confirm the presence of cancerous tissue. Various types of biopsy devices are available for the surgeons to be used on any organ in the human body. Traditional biopsy devices in combination with advanced imaging technologies such as MRI, ultrasound, CT scan, and others are used for their accuracy and minimal invasiveness in surgical procedures. Biopsies in critical areas of the body such as the lungs, liver, and kidneys require these type of integrated procedures.
Increasing incidence of various types of cancer, coupled with high awareness among the general population about chronic diseases in developed and developing economies are key factors driving growth of the global biopsy devices market. In addition, rising demand for minimally invasive procedures, and need for early diagnosis and treatment for chronic diseases are major factors expected to fuel growth to the global biopsy devices market over the forecast period.
However, high cost of advanced biopsy devices is a major factor restraining growth of the global biopsy devices market over the forecast period. In addition, stringent regulatory framework in developed countries for use of biopsy devices, coupled with issues pertaining to reimbursement are other major factors expected to hamper growth of the global biopsy devices market over the forecast period.
Currently, the market in North America dominates the global biopsy devices market in revenue terms owing to availability of appropriate equipment and infrastructure, high awareness among the general population about chronic disease diagnosis and treatment, and increasing incidence of chronic diseases in the region. Europe is currently the second-highest market in the global biopsy devices market, owing to increasing healthcare expenditure by governments of countries in the region, and relatively high disposable income among the general population. The market in Asia Pacific is projected to have the fastest growth in terms of revenue, owing to increase in number of patients suffering from chronic diseases, and rise in government initiatives for the improvement of healthcare facilities in the region.
Global biopsy devices market segmentation by device type:
- Breast biopsy devices
- Gastrointestinal (GI) biopsy devices
- Soft tissue biopsy devices
- Bronchial biopsy devices
- Gynecological biopsy devices
- Robotic biopsy devices
- Other devices (brushes, punches, and curettes)
Global biopsy devices market segmentation by application:
- Breast biopsy
- Gastrointestinal (GI) biopsy
- Others (thyroid, pancreas, and gall bladder)
Global biopsy devices market segmentation by imaging technology:
- CT scan
- Stereotactic-guided biopsy
- Ultrasound-guided biopsy
- MRI-guided biopsy
- Others (positron emission tomography, X-ray, and sonography)
Global biopsy devices market segmentation by end-user:
- Diagnostic centers
Global biopsy devices market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2016 Estimated Year 2017 Forecast Period 2017–2026 Revenue in US$
- R. Bard Inc.
- Leica Biosystems
- Dickinson and Company
- Ethicon EndoSurgery Inc.
- Fujifilm Medical Systems
- Veran Medical Technologies
- Boston Scientific Corporation
- Argon Medical Devices Inc.
- Intact Medical Corp.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!